Skip to main content
Top
Published in: Archives of Dermatological Research 1/2013

01-01-2013 | Original Paper

microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma

Authors: Mitsuhiko Etoh, Masatoshi Jinnin, Katsunari Makino, Keitaro Yamane, Wakana Nakayama, Jun Aoi, Noritoshi Honda, Ikko Kajihara, Takamitsu Makino, Satoshi Fukushima, Hironobu Ihn

Published in: Archives of Dermatological Research | Issue 1/2013

Login to get access

Abstract

Localized scleroderma (LSc), a connective tissue disorder restricted to the skin and subcutaneous tissue, is characterized by skin fibrosis due to an excessive deposition of types I collagen. The mechanism of such fibrosis is still unknown, but epigenetics may play some roles in the excessive collagen expression. In the present study, we investigated the mechanism of fibrosis seen in LSc, focusing on microRNA (miRNA). miRNA expression was determined by PCR array, real-time PCR, and in situ hybridization. The function of miRNA was evaluated using specific inhibitor. Immunoblotting was performed to detect α2(I) collagen protein. PCR array analysis using tissue miRNA demonstrated miR-7 level was significantly decreased in LSc skin as well as keloid tissue compared to normal skin in vivo. In situ hybridization also showed miR-7 expression in dermal fibroblasts was decreased in LSc dermis. The transfection of specific inhibitor for miR-7 into cultured normal dermal fibroblasts resulted in the up-regulation of α2(I) collagen protein in vitro. Also, the serum levels of miR-7 were significantly decreased in LSc patients compared with healthy controls, but serum miR-29a levels not. Systemic or local down-regulation of miR-7 may contribute to the pathogenesis of LSc via the overexpression of α2(I) collagen, and serum miR-7 may be useful as a disease marker. Investigation of the regulatory mechanisms of LSc by miRNA may lead to new treatments by the transfection into the lesional skin of this disease.
Literature
1.
go back to reference Arkachaisri T, Vilaiyuk S, Li S et al (2009) The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol 36:2819–2829PubMedCrossRef Arkachaisri T, Vilaiyuk S, Li S et al (2009) The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol 36:2819–2829PubMedCrossRef
2.
go back to reference Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA (2010) Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 49:373–381CrossRef Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA (2010) Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 49:373–381CrossRef
3.
go back to reference Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K (2006) Involvement of αvβ5 integrin in the establishment of autocrine TGF-β signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol 126:1761–1769PubMedCrossRef Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K (2006) Involvement of αvβ5 integrin in the establishment of autocrine TGF-β signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol 126:1761–1769PubMedCrossRef
4.
go back to reference Chen H, Shalom-Feuerstein R, Riley J et al (2010) miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem Biophys Res Commun 394:921–927PubMedCrossRef Chen H, Shalom-Feuerstein R, Riley J et al (2010) miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem Biophys Res Commun 394:921–927PubMedCrossRef
5.
go back to reference Cohly HP, Scott H, Ndebele K, Jenkins JK, Angel MF (2002) Differential gene expression of fibroblasts: keloid versus normal. Int J Mol Sci 3:1162–1176CrossRef Cohly HP, Scott H, Ndebele K, Jenkins JK, Angel MF (2002) Differential gene expression of fibroblasts: keloid versus normal. Int J Mol Sci 3:1162–1176CrossRef
6.
go back to reference Falanga V, Medsger TJ, Reichlin M (1985) Anti-nuclear and anti-single-stranded DNA in linear scleroderma. Arch Dermatol 123:350–353CrossRef Falanga V, Medsger TJ, Reichlin M (1985) Anti-nuclear and anti-single-stranded DNA in linear scleroderma. Arch Dermatol 123:350–353CrossRef
7.
go back to reference Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH (2010) The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 136:1–15PubMedCrossRef Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH (2010) The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 136:1–15PubMedCrossRef
8.
go back to reference Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K (1996) Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma. Br J Dermatol 134:843–847PubMedCrossRef Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K (1996) Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma. Br J Dermatol 134:843–847PubMedCrossRef
9.
go back to reference Jiang L, Liu X, Chen Z et al (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432:199–205PubMedCrossRef Jiang L, Liu X, Chen Z et al (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432:199–205PubMedCrossRef
10.
go back to reference Kanemaru H, Fukushima S, Yamashita J et al (2011) The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 61:187–193PubMedCrossRef Kanemaru H, Fukushima S, Yamashita J et al (2011) The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 61:187–193PubMedCrossRef
11.
go back to reference Kubo M, Ihn H, Yamane K, Tamaki K (2001) Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 44:731–734PubMedCrossRef Kubo M, Ihn H, Yamane K, Tamaki K (2001) Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 44:731–734PubMedCrossRef
12.
go back to reference Li J, Zhang Y, Kuruba R et al (2011) Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 80:191–200PubMedCrossRef Li J, Zhang Y, Kuruba R et al (2011) Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 80:191–200PubMedCrossRef
13.
go back to reference Long JM, Lahiri DK (2011) MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404:889–895PubMedCrossRef Long JM, Lahiri DK (2011) MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404:889–895PubMedCrossRef
14.
go back to reference Makino T, Jinnin M, Muchemwa FC et al (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br J Dermatol 162:717–723PubMedCrossRef Makino T, Jinnin M, Muchemwa FC et al (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br J Dermatol 162:717–723PubMedCrossRef
15.
go back to reference Maurer B, Stanczyk J, Jüngel A et al (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:1733–1743PubMedCrossRef Maurer B, Stanczyk J, Jüngel A et al (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:1733–1743PubMedCrossRef
16.
go back to reference Pandit KV, Milosevic J, Kaminski N (2011) MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157:191–199PubMedCrossRef Pandit KV, Milosevic J, Kaminski N (2011) MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157:191–199PubMedCrossRef
17.
go back to reference Sato S, Ihn H, Soma Y et al (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137–1141PubMedCrossRef Sato S, Ihn H, Soma Y et al (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137–1141PubMedCrossRef
18.
go back to reference Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:567–571PubMedCrossRef Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:567–571PubMedCrossRef
19.
go back to reference Takehara K, Kikuchi K, Soma Y, Igarashi A, Ishibashi Y (1990) Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 126:1368PubMedCrossRef Takehara K, Kikuchi K, Soma Y, Igarashi A, Ishibashi Y (1990) Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 126:1368PubMedCrossRef
20.
go back to reference Uziel Y, Krafchik B, Feldman B, Silverman E, Rubin L, Laxer R (1994) Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma. Arthritis Rheum 37:898–901PubMedCrossRef Uziel Y, Krafchik B, Feldman B, Silverman E, Rubin L, Laxer R (1994) Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma. Arthritis Rheum 37:898–901PubMedCrossRef
Metadata
Title
microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma
Authors
Mitsuhiko Etoh
Masatoshi Jinnin
Katsunari Makino
Keitaro Yamane
Wakana Nakayama
Jun Aoi
Noritoshi Honda
Ikko Kajihara
Takamitsu Makino
Satoshi Fukushima
Hironobu Ihn
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Archives of Dermatological Research / Issue 1/2013
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-012-1287-4

Other articles of this Issue 1/2013

Archives of Dermatological Research 1/2013 Go to the issue